Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minjee Kim

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Molecules (Basel, Switzerland)|December 11, 2022
Immune-Enhancing Effect of <i>Sargassum horneri</i> on Cyclophosphamide-Induced Immunosuppression in BALB/c Mice and Primary Cultured SplenocytesHyo In Kim, Dong-Sub Kim, Yunu Jung, et al.
Frontiers in Immunology|July 23, 2024
Timing of maternal vaccination against COVID-19 for effective protection of neonates: cohort studyAleksandra Nowakowska, Seung Mi Lee, Minjee Kim, et al.
Critical Care Medicine|January 18, 2018
Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic EncephalopathyEric Michael Liotta, Anna L Romanova, Bryan D Lizza, et al.
BMJ Open|February 23, 2023
MidCog study: a prospective, observational cohort study investigating health literacy, self-management skills and cognitive function in middle-aged adultsMinjee Kim, Mary J Kwasny, Stacy C Bailey, et al.
BMJ Open|October 18, 2023
Primary care detection of cognitive impairment leveraging health and consumer technologies in underserved US communities: protocol for a pragmatic randomised controlled trial of the MyCog paradigmRebecca Lovett, Morgan Bonham, Julia Yoshino Benavente, et al.
American Journal of Obstetrics & Gynecology MFM|June 13, 2024
Restless legs syndrome and adverse perinatal outcomesRachel Friedlander, Xiaoning Huang, Minjee Kim, et al.
Molecular Cancer Therapeutics|July 5, 2018
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain BarrierMinjee Kim, Daniel J Ma, David Calligaris, et al.
The New England Journal of Medicine|February 8, 2024
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging SelectionGregory W Albers, Mouhammad Jumaa, Barbara Purdon, et al.
Neuro-Oncology|September 8, 2025
Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patientsJu-Hee Oh, Sarah K Reed, Cecile Riviere-Cazaux, et al.
Epilepsia|September 13, 2025
Quality of life over time after new onset refractory status epilepticusMatthew D Gruen, Margaret T Gopaul, Anthony D Jimenez, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Molecules (Basel, Switzerland)|December 11, 2022
Immune-Enhancing Effect of <i>Sargassum horneri</i> on Cyclophosphamide-Induced Immunosuppression in BALB/c Mice and Primary Cultured SplenocytesHyo In Kim, Dong-Sub Kim, Yunu Jung, et al.
Frontiers in Immunology|July 23, 2024
Timing of maternal vaccination against COVID-19 for effective protection of neonates: cohort studyAleksandra Nowakowska, Seung Mi Lee, Minjee Kim, et al.
Critical Care Medicine|January 18, 2018
Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic EncephalopathyEric Michael Liotta, Anna L Romanova, Bryan D Lizza, et al.
BMJ Open|February 23, 2023
MidCog study: a prospective, observational cohort study investigating health literacy, self-management skills and cognitive function in middle-aged adultsMinjee Kim, Mary J Kwasny, Stacy C Bailey, et al.
BMJ Open|October 18, 2023
Primary care detection of cognitive impairment leveraging health and consumer technologies in underserved US communities: protocol for a pragmatic randomised controlled trial of the MyCog paradigmRebecca Lovett, Morgan Bonham, Julia Yoshino Benavente, et al.
American Journal of Obstetrics & Gynecology MFM|June 13, 2024
Restless legs syndrome and adverse perinatal outcomesRachel Friedlander, Xiaoning Huang, Minjee Kim, et al.
Molecular Cancer Therapeutics|July 5, 2018
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain BarrierMinjee Kim, Daniel J Ma, David Calligaris, et al.
The New England Journal of Medicine|February 8, 2024
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging SelectionGregory W Albers, Mouhammad Jumaa, Barbara Purdon, et al.
Neuro-Oncology|September 8, 2025
Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patientsJu-Hee Oh, Sarah K Reed, Cecile Riviere-Cazaux, et al.
Epilepsia|September 13, 2025
Quality of life over time after new onset refractory status epilepticusMatthew D Gruen, Margaret T Gopaul, Anthony D Jimenez, et al.
Pageof 15